Global Biopharmaceutical and Vaccines Market 2021 by Company, Regions, Type and Applicati...

  • Report ID:57216
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107

Free Sample

Request Customization

Request A Callback

Enquiry before buying

 
                              

                               
The Biopharmaceutical and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biopharmaceutical and Vaccines size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biopharmaceutical and Vaccines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biopharmaceutical and Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Biopharmaceutical
    Vaccine Production

Market segment by Application, can be divided into
    Pharmaceuticals Industry
    Clinical Diagnosis
    Scientific Research
    Others

Market segment by players, this report covers
    Novartis
    Pfizer
    Sanofi
    Roche
    Abbott
    Biogen Idec
    Regeneron Pharmaceuticals
    Alexion Pharmaceuticals
    Johnson and Johnson
    GlaxoSmithKline
    Merck
    Lonza
    Boehringer Ingelheim
    Rentschler

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
                           

                       
                        

                         
1 Market Overview
    1.1 Product Overview and Scope of Biopharmaceutical and Vaccines
    1.2 Classification of Biopharmaceutical and Vaccines by Type
        1.2.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2020
        1.2.3 Biopharmaceutical
        1.2.4 Vaccine Production
    1.3 Global Biopharmaceutical and Vaccines Market by Application
        1.3.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Pharmaceuticals Industry
        1.3.3 Clinical Diagnosis
        1.3.4 Scientific Research
        1.3.5 Others
    1.4 Global Biopharmaceutical and Vaccines Market Size & Forecast
    1.5 Global Biopharmaceutical and Vaccines Market Size and Forecast by Region
        1.5.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Biopharmaceutical and Vaccines Market Size by Region, (2016-2021)
        1.5.3 North America Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
        1.5.4 Europe Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
        1.5.6 South America Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biopharmaceutical and Vaccines Market Drivers
        1.6.2 Biopharmaceutical and Vaccines Market Restraints
        1.6.3 Biopharmaceutical and Vaccines Trends Analysis
2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Biopharmaceutical and Vaccines Product and Solutions
        2.1.4 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Biopharmaceutical and Vaccines Product and Solutions
        2.2.4 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Biopharmaceutical and Vaccines Product and Solutions
        2.3.4 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Sanofi Recent Developments and Future Plans
    2.4 Roche
        2.4.1 Roche Details
        2.4.2 Roche Major Business
        2.4.3 Roche Biopharmaceutical and Vaccines Product and Solutions
        2.4.4 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Roche Recent Developments and Future Plans
    2.5 Abbott
        2.5.1 Abbott Details
        2.5.2 Abbott Major Business
        2.5.3 Abbott Biopharmaceutical and Vaccines Product and Solutions
        2.5.4 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Abbott Recent Developments and Future Plans
    2.6 Biogen Idec
        2.6.1 Biogen Idec Details
        2.6.2 Biogen Idec Major Business
        2.6.3 Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
        2.6.4 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Biogen Idec Recent Developments and Future Plans
    2.7 Regeneron Pharmaceuticals
        2.7.1 Regeneron Pharmaceuticals Details
        2.7.2 Regeneron Pharmaceuticals Major Business
        2.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
        2.7.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
    2.8 Alexion Pharmaceuticals
        2.8.1 Alexion Pharmaceuticals Details
        2.8.2 Alexion Pharmaceuticals Major Business
        2.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
        2.8.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Alexion Pharmaceuticals Recent Developments and Future Plans
    2.9 Johnson and Johnson
        2.9.1 Johnson and Johnson Details
        2.9.2 Johnson and Johnson Major Business
        2.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
        2.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Johnson and Johnson Recent Developments and Future Plans
    2.10 GlaxoSmithKline 
        2.10.1 GlaxoSmithKline Details
        2.10.2 GlaxoSmithKline Major Business
        2.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
        2.10.4 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 GlaxoSmithKline Recent Developments and Future Plans
    2.11 Merck
        2.11.1 Merck Details
        2.11.2 Merck Major Business
        2.11.3 Merck Biopharmaceutical and Vaccines Product and Solutions
        2.11.4 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Merck Recent Developments and Future Plans
    2.12 Lonza
        2.12.1 Lonza Details
        2.12.2 Lonza Major Business
        2.12.3 Lonza Biopharmaceutical and Vaccines Product and Solutions
        2.12.4 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Lonza Recent Developments and Future Plans
    2.13 Boehringer Ingelheim
        2.13.1 Boehringer Ingelheim Details
        2.13.2 Boehringer Ingelheim Major Business
        2.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
        2.13.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.14 Rentschler
        2.14.1 Rentschler Details
        2.14.2 Rentschler Major Business
        2.14.3 Rentschler Biopharmaceutical and Vaccines Product and Solutions
        2.14.4 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Rentschler Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biopharmaceutical and Vaccines Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biopharmaceutical and Vaccines Players Market Share
        3.2.2 Top 10 Biopharmaceutical and Vaccines Players Market Share
        3.2.3 Market Competition Trend
    3.3 Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biopharmaceutical and Vaccines Revenue and Market Share by Type (2016-2021)
    4.2 Global Biopharmaceutical and Vaccines Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2016-2021)
    5.2 Biopharmaceutical and Vaccines Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
    6.2 North America Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
    6.3 North America Biopharmaceutical and Vaccines Market Size by Country
        6.3.1 North America Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
        6.3.2 United States Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        6.3.3 Canada Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        6.3.4 Mexico Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
    7.2 Europe Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
    7.3 Europe Biopharmaceutical and Vaccines Market Size by Country
        7.3.1 Europe Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
        7.3.2 Germany Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        7.3.3 France Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        7.3.5 Russia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        7.3.6 Italy Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
    8.2 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
    8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region
        8.3.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2016-2026)
        8.3.2 China Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        8.3.3 Japan Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        8.3.4 South Korea Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        8.3.5 India Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        8.3.7 Australia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
    9.2 South America Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
    9.3 South America Biopharmaceutical and Vaccines Market Size by Country
        9.3.1 South America Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
        9.3.2 Brazil Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        9.3.3 Argentina Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
    10.2 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
    10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country
        10.3.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
        10.3.2 Turkey Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
        10.3.4 UAE Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer
Read More 
                

                 
List of Tables
    Table 1. Global Biopharmaceutical and Vaccines Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Biopharmaceutical and Vaccines Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Biopharmaceutical and Vaccines Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2021-2026)
    Table 6. Novartis Corporate Information, Head Office, and Major Competitors
    Table 7. Novartis Major Business
    Table 8. Novartis Biopharmaceutical and Vaccines Product and Solutions
    Table 9. Novartis Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 11. Pfizer Major Business
    Table 12. Pfizer Biopharmaceutical and Vaccines Product and Solutions
    Table 13. Pfizer Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 15. Sanofi Major Business
    Table 16. Sanofi Biopharmaceutical and Vaccines Product and Solutions
    Table 17. Sanofi Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Roche Corporate Information, Head Office, and Major Competitors
    Table 19. Roche Major Business
    Table 20. Roche Biopharmaceutical and Vaccines Product and Solutions
    Table 21. Roche Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Abbott Corporate Information, Head Office, and Major Competitors
    Table 23. Abbott Major Business
    Table 24. Abbott Biopharmaceutical and Vaccines Product and Solutions
    Table 25. Abbott Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Biogen Idec Corporate Information, Head Office, and Major Competitors
    Table 27. Biogen Idec Major Business
    Table 28. Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
    Table 29. Biogen Idec Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 31. Regeneron Pharmaceuticals Major Business
    Table 32. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
    Table 33. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Alexion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 35. Alexion Pharmaceuticals Major Business
    Table 36. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
    Table 37. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
    Table 39. Johnson and Johnson Major Business
    Table 40. Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
    Table 41. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 43. GlaxoSmithKline Major Business
    Table 44. GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
    Table 45. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Merck Corporate Information, Head Office, and Major Competitors
    Table 47. Merck Major Business
    Table 48. Merck Biopharmaceutical and Vaccines Product and Solutions
    Table 49. Merck Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Lonza Corporate Information, Head Office, and Major Competitors
    Table 51. Lonza Major Business
    Table 52. Lonza Biopharmaceutical and Vaccines Product and Solutions
    Table 53. Lonza Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 55. Boehringer Ingelheim Major Business
    Table 56. Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
    Table 57. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Rentschler Corporate Information, Head Office, and Major Competitors
    Table 59. Rentschler Major Business
    Table 60. Rentschler Biopharmaceutical and Vaccines Product and Solutions
    Table 61. Rentschler Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Biopharmaceutical and Vaccines Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Biopharmaceutical and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
    Table 66. Biopharmaceutical and Vaccines Mergers & Acquisitions in the Past Five Years
    Table 67. Biopharmaceutical and Vaccines New Entrants and Expansion Plans
    Table 68. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Biopharmaceutical and Vaccines Revenue Share by Type (2016-2021)
    Table 70. Global Biopharmaceutical and Vaccines Revenue Forecast by Type (2021-2026)
    Table 71. Global Biopharmaceutical and Vaccines Revenue by Application (2016-2021)
    Table 72. Global Biopharmaceutical and Vaccines Revenue Forecast by Application (2021-2026)
    Table 73. North America Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Biopharmaceutical and Vaccines Picture
    Figure 2. Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2020
    Figure 3. Biopharmaceutical
    Figure 4. Vaccine Production
    Figure 5. Biopharmaceutical and Vaccines Revenue Market Share by Application in 2020
    Figure 6. Pharmaceuticals Industry Picture
    Figure 7. Clinical Diagnosis Picture
    Figure 8. Scientific Research Picture
    Figure 9. Others Picture
    Figure 10. Global Biopharmaceutical and Vaccines Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global Biopharmaceutical and Vaccines Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2016-2026)
    Figure 13. Global Biopharmaceutical and Vaccines Revenue Market Share by Region in 2020
    Figure 14. North America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Biopharmaceutical and Vaccines Market Drivers
    Figure 20. Biopharmaceutical and Vaccines Market Restraints
    Figure 21. Biopharmaceutical and Vaccines Market Trends
    Figure 22. Novartis Recent Developments and Future Plans
    Figure 23. Pfizer Recent Developments and Future Plans
    Figure 24. Sanofi Recent Developments and Future Plans
    Figure 25. Roche Recent Developments and Future Plans
    Figure 26. Abbott Recent Developments and Future Plans
    Figure 27. Biogen Idec Recent Developments and Future Plans
    Figure 28. Regeneron Pharmaceuticals Recent Developments and Future Plans
    Figure 29. Alexion Pharmaceuticals Recent Developments and Future Plans
    Figure 30. Johnson and Johnson Recent Developments and Future Plans
    Figure 31. GlaxoSmithKline Recent Developments and Future Plans
    Figure 32. Merck Recent Developments and Future Plans
    Figure 33. Lonza Recent Developments and Future Plans
    Figure 34. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 35. Rentschler Recent Developments and Future Plans
    Figure 36. Global Biopharmaceutical and Vaccines Revenue Share by Players in 2020
    Figure 37. Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 38. Global Top 3 Players Biopharmaceutical and Vaccines Revenue Market Share in 2020
    Figure 39. Global Top 10 Players Biopharmaceutical and Vaccines Revenue Market Share in 2020
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 41. Global Biopharmaceutical and Vaccines Revenue Share by Type in 2020
    Figure 42. Global Biopharmaceutical and Vaccines Market Share Forecast by Type (2021-2026)
    Figure 43. Global Biopharmaceutical and Vaccines Revenue Share by Application in 2020
    Figure 44. Global Biopharmaceutical and Vaccines Market Share Forecast by Application (2021-2026)
    Figure 45. North America Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
    Figure 46. North America Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
    Figure 47. North America Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
    Figure 48. United States Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Canada Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Mexico Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Europe Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
    Figure 52. Europe Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
    Figure 53. Europe Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
    Figure 54. Germany Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. France Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. United Kingdom Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Russia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Italy Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
    Figure 60. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
    Figure 61. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Share by Region (2016-2026)
    Figure 62. China Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Japan Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South Korea Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. India Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Southeast Asia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Australia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South America Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
    Figure 69. South America Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
    Figure 70. South America Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
    Figure 71. Brazil Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Argentina Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
    Figure 74. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
    Figure 75. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
    Figure 76. Turkey Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. UAE Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Purchase Report

Single User 3480
Multi User 5220
Corporate User 6960
Buy

Speak To Analyst

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

Related Reports

Global IVD Infectious Disease Market Insights and Forecast to 2028
  • Report ID:183781
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107
  • 3480

Global Circulating Tumor Cells (CTC) Market Insights, Forecast to 2028
  • Report ID:185494
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107
  • 3480

Global Pigmentation Disorder Treatment Market Insights, Forecast to 2028
  • Report ID:185700
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107
  • 3480

Global Receptors Assay Market Insights, Forecast to 2028
  • Report ID:185866
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107
  • 3480

Global Single-Use Technologies for the Biologic Market Insights, Forecast to 2028
  • Report ID:186036
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 107
  • 3480

clock

+1  347 708 0418

clocksales@acorinsights.com

trusted-site ssl paypal

COPYRIGHT © 2021 Acor Insights | All Rights Reserved.